Ravi Maharjan | Pharmaceutics | Best Researcher Award

Published on by Academic Achievements

Dr. Ravi Maharjan | Pharmaceutics | Best Researcher Award

Dr. Ravi Maharjan | Pharmaceutics | Assistant Research Professor at Yonsei University | South Korea

Pharmaceutics is the foundation of Dr. Ravi Maharjan’s distinguished career as a research professor at Yonsei University, Korea, where he has been at the forefront of integrating AI/ML and Digital Twin technologies to revolutionize biopharmaceutical manufacturing, particularly in mRNA and siRNA-based lipid nanoparticle (LNP) vaccine development. Dr. Ravi Maharjan earned his PhD in Pharmaceutics and has since developed a deep expertise in biopharmaceutical process optimization, continuous manufacturing, lyophilization, stabilization strategies, and innovative delivery approaches targeting ocular and brain tissues. His professional experience spans extensive teaching, mentoring, and research leadership roles, where he has guided national and international collaborations with universities, pharmaceutical companies, and research institutions, including Pusan National University, CHA University, RCPE, RNAAnalytics Austria, and IMDEA Spain, demonstrating his ability to bridge academic research with industrial applications. Dr. Ravi Maharjan’s research interests focus on applying AI/ML algorithms for predictive modeling of complex pharmaceutical processes, optimizing formulations, ensuring protein stability, and enhancing the physical and biological stability of therapeutics. His work integrates pharmaceutics, process analytical technologies (PAT), quality by design (QbD), experimental design (DOE), and computational modeling to advance next-generation biopharmaceutical platforms. Among his key research skills are data-driven formulation design, predictive modeling, digital twin deployment, computational optimization of LNP delivery, lyophilized formulation screening, molecular simulation, process monitoring, and the translation of lab-scale research into continuous manufacturing systems. Dr. Ravi Maharjan has an impressive record of scholarly contributions, including over 23 SCIE Q1 publications, two books, two book chapters, more than 115 peer-review assignments, over 30 conference presentations, and eight invited talks. He has served as associate editor for Pharmaceutical Science and Technology (USA), editorial board member for Scientific Reports (Nature Portfolio, UK), Pharmaceutics (Switzerland), and Current Pharmaceutical Biotechnology (UAE), as well as conference organizer for multiple international events. His awards and honors recognize his contributions to both fundamental pharmaceutics and applied biopharmaceutical manufacturing, highlighting his excellence in research innovation and mentorship. Dr. Ravi Maharjan has demonstrated outstanding ability to secure funding, lead interdisciplinary projects, and foster scientific collaboration across countries and institutions, contributing to the advancement of mRNA and siRNA therapeutics, the optimization of excipients, and the improvement of drug delivery systems. His work on digital twins and AI/ML-driven process optimization has paved the way for predictive control in continuous manufacturing, ensuring reproducibility, efficiency, and quality in pharmaceutical production. In conclusion, Dr. Ravi Maharjan embodies the integration of scientific innovation, computational methods, and practical pharmaceutics expertise, making significant impacts in biopharmaceutical sciences, while continuing to mentor the next generation of researchers, drive technological innovation, and advance knowledge in AI-assisted pharmaceutical development.

Profile: Google Scholar

Featured Publications 

  1. Tripathi, J., Thapa, P., Maharjan, R., & Jeong, S. H. (2019). Current state and future perspectives on gastroretentive drug delivery systems. Citations: 246
  2. Maharjan, R., Hada, S., Lee, J. E., Han, H. K., Kim, K. H., Seo, H. J., Foged, C., … (2023). Comparative study of lipid nanoparticle-based mRNA vaccine bioprocess with machine learning and combinatorial artificial neural network-design of experiment approach. Citations: 48
  3. Maharjan, R., Kim, K. H., Lee, K., Han, H. K., & Jeong, S. H. (2024). Machine learning-driven optimization of mRNA-lipid nanoparticle vaccine quality with XGBoost/Bayesian method and ensemble model approaches. Citations: 44
  4. Maharjan, R., & Jeong, S. H. (2020). High shear seeded granulation: Its preparation mechanism, formulation, process, evaluation, and mathematical simulation. Citations: 37
  5. Bhujel, R., Maharjan, R., Kim, N. A., & Jeong, S. H. (2021). Practical quality attributes of polymeric microparticles with current understanding and future perspectives. Citations: 29
  6. Maharjan, R., Lee, J. C., Lee, K., Han, H. K., Kim, K. H., & Jeong, S. H. (2023). Recent trends and perspectives of artificial intelligence-based machine learning from discovery to manufacturing in biopharmaceutical industry. Citations: 28
  7. Kim, K. H., Lee, J. E., Lee, J. C., Maharjan, R., Oh, H., Lee, K., Kim, N. A., & Jeong, S. H. (2023). Optimization of HPLCCAD method for simultaneous analysis of different lipids in lipid nanoparticles with analytical QbD. Citations: 17

 

Satyajit Tripathy | Nanodrug | Distinguished Scientist Award

Published on by Academic Achievements

Dr. Satyajit Tripathy | Nanodrug | Distinguished Scientist Award

Dr. Satyajit Tripathy | Nanodrug | Assistant Professor at Amity University, India

Dr. Satyajit Tripathy is a distinguished academic and researcher in the field of Human Physiology, specializing in Microbiology and Immunology. He holds an M.Sc. in Human Physiology with specialization in Microbiology and Immunology from Vidyasagar University and a Ph.D. in Physiology from the same institution, where his doctoral research focused on the antimalarial efficacy of chitosan nanoparticle-conjugated chloroquine against Plasmodium berghei, demonstrating pioneering work in nanomedicine. Dr. Tripathy has extensive professional experience as an Assistant Professor at Amity University, Noida, and Chandigarh University, and has contributed as a guest lecturer and senior lecturer at multiple Indian and international institutions, including the University of the Free State, South Africa, and Michigan State University, USA. His research interests encompass antimalarial therapies, anticancer nanoparticles, immunomodulation, and translational biomedical applications, with skills in molecular biology, nanoparticle synthesis, immunoassays, and preclinical model evaluation. He has led and participated in numerous international research projects and has a strong record of publications in high-impact journals, with a total citation count exceeding 2,500, h-index of 27, and i10-index of 47. Dr. Tripathy has been recognized for his contributions through awards, honors, and leadership roles in academic and research communities, actively participating in professional societies such as IEEE and ACM. His work demonstrates a commitment to scientific excellence, innovation, mentorship, and collaborative research. In conclusion, Dr. Satyajit Tripathy exemplifies an accomplished researcher and educator whose expertise, global research experience, and dedication to advancing human physiology and biomedical sciences make him a valuable contributor to the scientific community with significant potential for future impact.

Profile: Google Scholar | Scopus

Featured Publications

  1. Erukainure, O. L., Chukwuma, C. I., Nambooze, J., Tripathy, S., Salau, V. F., Olofinsan, K., Ogunlakin, A. D., Ebuehi, O. A. T., & Unuofin, J. O. (2025). Tea Consumption and Diabetes: A Comprehensive Pharmacological Review of Black, White, Green, Oolong, and Pu-erh Teas. Plants. 15 citations.

  2. Nina, N., Burgos-Edwards, A., Theoduloz, C., Tripathy, S., Matsabisa, M. G., & Schmeda-Hirschmann, G. (2024). Chemical Profiling, Enzyme Inhibitory Activity and Antioxidant Capacity of South African Herbal Teas: Buddleja saligna, Lippia javanica, L. scaberrima and Phyla dulcis. Antioxidants. 12 citations.

  3. Bhattacharya, D., Mukhopadhyay, M., Shivam, K., Tripathy, S., Patra, R., & Pramanik, A. (2023). Recent Developments in Photodynamic Therapy and Its Application Against Multidrug Resistant Cancers. Biomedical Materials. 10 citations.

  4. Mutombo, P. N., Kasilo, O. M., James, P. B., Wardle, J., Kunle, O., Katerere, D., Wambebe, C., Matsabisa, M. G., Rahmatullah, M., Nikiema, J. B., Mukankubito, I., Sheridan, R., Sanogo, R., Nissapatorn, V., Sivakorn, C., Tripathy, S., & Goyal, R. (2023). Experiences and Challenges of African Traditional Medicine: Lessons from COVID-19 Pandemic. BMJ Global Health. 18 citations.

  5. Mukherjee, P., Tripathy, S., Matsabisa, M. G., & Sahu, S. K. (2022). Development of Upconversion-NMOFs Nanocomposite Conjugated with Gold Nanoparticles for NIR Light-Triggered Combinational Chemophotothermal Therapy. Journal of Photochemistry & Photobiology, A: Chemistry. 14 citations.

  6. Das, S., Tripathy, S., Das, A., Sharma, M. K., Nag, A., Hati, A. K., & Roy, S. (2022). Genomic Characterization of Plasmodium falciparum Genes Associated with Anti-Folate Drug Resistance and Treatment Outcomes in Eastern India: A Molecular Surveillance Study. Frontiers in Cellular and Infection Microbiology. 16 citations.

  7. Matsabisa, M. G., Bala, A., Tripathy, S., Diganshu, M. M., Rautenbach, F. G., & Dassarma, B. (2022). Study on South African Indigenous Teas – Antioxidant Potential, Nutritional Content and Hypoxia-Induced Cyclooxygenase Inhibition on U87 MG Cell Line. Molecules. 11 citations.